Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04110704
Other study ID # 261294
Secondary ID 42833
Status Recruiting
Phase N/A
First received
Last updated
Start date October 2, 2019
Est. completion date October 1, 2022

Study information

Verified date July 2021
Source Guy's and St Thomas' NHS Foundation Trust
Contact Agnieszka Glazewska-Hallin
Phone 020 7188
Email agnieszka.glazewska-hallin@kcl.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

CRAFT-OBS: Observational Study; To evaluate subsequent pregnancy risk of preterm birth in women with a history of previous caesarean in established labour. This prospective study using clinically acquired cervical length and quantitative fetal fibronectin data will help establish a predictive model of preterm birth <34 weeks and <37 weeks. CRAFT-RCT: Randomised controlled trial arm; To assess treatment for short cervix in women at high risk of preterm birth following a caesarean section at full dilatation CRAFT-IMG: Imaging sub-study; To aid understanding of micro and macrostructural features within the cervix which predisposes to preterm birth in women with a previous full dilatation caesarean section. This will use MRI and an advanced transvaginal ultrasound protocol and to assess if structural changes can be visualised in the cervix.


Recruitment information / eligibility

Status Recruiting
Enrollment 1000
Est. completion date October 1, 2022
Est. primary completion date April 1, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 16 Years and older
Eligibility CRAFT-OBS Inclusion Criteria: - Pregnant women under 23+6 weeks gestation with a history of previous caesarean section in labour. - Singleton pregnancy. - Willing and able to give informed consent (with or without interpreter). Exclusion Criteria: - Under 16 years of age. - Inability to give informed consent. - Previous caesarean section carried out before labour. - Women who have been commenced on management with progesterone, a cerclage or arabin pessary as part of their care or another research study CRAFT-RCT: Inclusion criteria: - Pregnant women up to 23+6 weeks gestation with a history of FDCS. - Short cervix (<=25mm) on transvaginal ultrasound scan. Exclusion criteria: - Women with persistent fresh vaginal bleeding evident on speculum examination. - Women with visible fetal membranes evident on speculum examination or open cervix on ultrasound scan. - Women with severe abdominal pain/evidence of sepsis (as judged by attending clinician). - Known significant congenital or structural or chromosomal fetal abnormality. - Suspected or proven rupture of the fetal membranes at the time of recruitment. CRAFT-IMG Inclusion criteria: - Pregnant women between 14+0 and 23+6 weeks gestation with a history of FDCS. Exclusion criteria: - Contraindications to MRI, e.g. claustrophobia, BMI >40 kg/m2 (due to technical limitations of scanner) or a women with a non-MRI compatible metallic implant.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Insertion of transvaginal cerclage
Transvaginal cerclage is inserted in women with a high risk of preterm birth. However it is unknown whether this alongside cervical length monitoring improves the incidence of preterm birth. The cerclage is inserted under regional analgesia.

Locations

Country Name City State
United Kingdom Guy's and St Thomas' Hospital NHS Foundation Trust London

Sponsors (3)

Lead Sponsor Collaborator
Guy's and St Thomas' NHS Foundation Trust King's College London, University College, London

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary CRAFT-OBS: Number of participants with spontaneous preterm birth rate < 37 weeks gestation Up to 42 weeks
Primary CRAFT-RCT: Number of participants with spontaneous preterm birth <34 weeks gestation Up to 42 weeks
Secondary CRAFT-OBS: Short-term pregnancy and neonatal outcomes, including a composite of neonatal death and morbidity. We will assess the number of antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services. Up to 48 weeks
Secondary CRAFT-OBS: Number of participants with adverse perinatal outcome, defined as a composite outcome of death (antepartum/intrapartum stillbirths plus neonatal deaths prior to discharge from neonatal services) Up to 48 weeks
Secondary CRAFT-OBS: Number of participants who deliver <34 weeks gestation Up to 42 weeks
Secondary CRAFT-OBS: Gestation at delivery The proportion of participants who delivery at each gestation of completed weeks Up to 42 weeks
Secondary CRAFT-OBS: Late miscarriage (14+0-23+6 weeks) rate Up to 42 weeks
Secondary CRAFT-OBS: Any cervical length measurements taken antenatally Up to 42 weeks
Secondary CRAFT-OBS: Number of antenatal hospital appointments Up to 42 weeks
Secondary CRAFT-OBS: Number of hospital admissions Up to 42 weeks
Secondary CRAFT-OBS: cervicovaginal fetal fibronectin protein levels taken at any gestation if taken Up to 42 weeks
Secondary CRAFT-OBS: Number of ultrasound indicated antenatal interventions Up to 42 weeks
Secondary CRAFT-OBS: Predictive modelling (QUIPP app) to evaluate the ability of CL and fFN to determine risk of preterm birth <34 and <37 weeks Up to 42 weeks
Secondary CRAFT-OBS: Number of participants with other maternal and fetal morbidities, as per COPOP core outcome set for preterm birth intervention studies COPOP core outcomes Up to 48 weeks
Secondary CRAFT-RCT: Number of participants with an adverse perinatal outcome Up to 48 weeks
Secondary CRAFT-RCT: Gestation at delivery Proportion of participants who deliver at each gestation of completed weeks Up to 42 weeks
Secondary CRAFT-RCT: Number of women needing insertion of a rescue cerclage (done when membranes exposed or bulging) Up to 30 weeks
Secondary CRAFT-RCT: Time between intervention and delivery. Up to 42 weeks
Secondary CRAFT-RCT - Health costs at 28 days post-delivery. Up to 48 weeks
Secondary CRAFT-IMG: Evidence of cervical injury Size of any cervical lesion and its location seen on MRI or ultrasound scans Up to 40 weeks
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Not yet recruiting NCT03418311 - Cervical Pessary Treatment for Prevention of s PTB in Twin Pregnancies on Children`s Long-Term Outcome N/A
Not yet recruiting NCT03418012 - Prevention of sPTB With Early Cervical Pessary Treatment in Women at High Risk for PTB N/A
Completed NCT02993744 - Maternal Inflammatory Parameters Within Routine Treatment With Betamethasone N/A
Active, not recruiting NCT02673216 - Infection and Adverse Pregnancy Outcome
Completed NCT01683565 - Preemie Tots: A Pilot Study to Understand the Effects of Prematurity in Toddlerhood Phase 4
Completed NCT01412931 - Protein and Ultrasound Indicators of Preterm Birth N/A
Completed NCT01460576 - Improving Prematurity-Related Respiratory Outcomes at Vanderbilt N/A
Completed NCT02606058 - The Australian Placental Transfusion Study (APTS): Should Very Pre Term Babies Receive a Placental Blood Transfusion at Birth Via Deferring Cord Clamping Versus Standard Cord Clamping Procedures? N/A
Terminated NCT03715530 - Use of Placental Alpha Microglobulin-1(PAMG-1) to Diagnose Premature Rupture of Membranes in Pregnant Women N/A
Completed NCT00422526 - Progesterone for Prevention of Preterm Birth in Women With Short Cervix: Randomized Controlled Trial Phase 3
Enrolling by invitation NCT04251260 - Effectiveness of Positioning in Preterm Neonates N/A
Completed NCT03668860 - India Dexamethasone and Betamethasone Phase 1
Recruiting NCT03638037 - Correlation Between Maternal Vitamin D Level And Preterm Birth
Completed NCT02225353 - Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery Phase 2
Recruiting NCT03992534 - The FLIP-1 Study: Vaginal Lactobacillus Supplementation in Women at High Risk of Preterm Birth Phase 1
Completed NCT03144141 - Association Between EHG and Risk of Preterm Delivery in Women Hospitalized for Threatened Premature Delivery N/A
Completed NCT05210985 - Examination of the Relationship Between Home Affordances With Development
Completed NCT04021654 - What is the Future of Vulnerable New-borns